CEA Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CEA Antibodies for research in cancer biology and diagnostics. CEA Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Carcinoembryonic antigen (CEA) is a glycoprotein involved in cell adhesion and is primarily associated with colorectal cancer, although it can also be elevated in other malignancies. The measurement of CEA levels in serum is commonly used as a tumor marker to monitor treatment response and disease progression. Understanding the role of CEA in tumor biology is crucial for developing targeted therapies and improving patient outcomes. CEA monoclonal antibodies enable researchers to explore cellular pathways and molecular mechanisms involved in cancer development. Investigating CEA expression patterns helps identify potential therapeutic targets and biomarkers for early cancer detection. Advanced research techniques using CEA monoclonal antibodies support the development of novel diagnostic tools and treatment strategies. Santa Cruz Biotechnology monoclonal antibodies for CEA research contribute to advancing cancer research and improving diagnostic capabilities in the scientific community.